alzheimer-s-disease

Documents about alzheimer-s-disease

• Cognitive resilience in preclinical Alzheimer's disease: Higher NPTX2 and VGF levels are associated with reduced cognitive decline.#645365NCBI PubMed Central
• Methodological approaches to account for assay changes in longitudinal biomarker analysis: insights from Alzheimer’s blood biomarkers in the MEMENTO cohort#280350HAL (France)
• Ceramide and Sphingosine-1-Phosphate in Neurodegenerative Disorders and Their Potential Involvement in Therapy#360093IRIS
• Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference#620173eScholarship
• Caregiver burden and quality of life associated with behavioral and psychological symptoms of Alzheimer's disease: A web-based cross-sectional survey study.#186074NCBI PubMed Central
• circPDE4B downregulation triggers GEMIN5‑dependent translational stress response and autophagy to reduce MAPT pathology#215368Europe PMC
• Higher physical activity levels mitigate synaptic protein loss and cognitive deterioration in aging and in Alzheimer's disease: a 10-year longitudinal study.#375195NCBI PubMed Central
• 42 U.S.C. § 11292 — Education of public, individuals with Alzheimer’s disease and their families, and health and long-term care providers#590080US Code (LII)
• Associations between frailty, biomarkers of cerebral pathology, cognitive and neuropsychiatric symptoms: a memory clinic study#15454HAL (France)
• Transdiagnostic quantitative assessment of dementias using in vivo MRI and data-driven disease progression modelling: a case study in Alzheimer's disease and dementia with Lewy bodies#440253bioRxiv / medRxiv
• lncRNAs: key player in Aβ deposition#4583Europe PMC
• Blood-based proteomic signatures of spontaneous menopause: Implications for later-life brain aging and Alzheimer’s disease risk#5039Europe PMC
• Stages of objective memory impairment are associated with accelerated brain aging#5441Europe PMC
• Astrocyte Mitochondrial UCP4 Reprograms Neuronal Network Oscillations via GDNF-Dependent K(+)-Ca(2+) Signaling in Alzheimer's Disease Mice.#12731NCBI PubMed Central
• Beyond the neuron: Exosomes as intercellular modulators of mitochondrial networks in the pathogenesis and treatment of Alzheimer's disease.#13447NCBI PubMed Central
• Blood‐based biomarkers for Alzheimer's disease in primary care: A French qualitative study exploring perspectives of general practitioners#15440HAL (France)
• Amyloid-beta-targeting monoclonal antibodies for people with mild cognitive impairment or mild dementia due to Alzheimer's disease.#18484NCBI PubMed Central
• Effects of exercise on cognitive function in older patients with Alzheimer’s disease: a meta-regression and meta-analysis.#125507NCBI PubMed Central
• Evaluation of Precuneus and Fusiform Gyrus-Based Radiomic biomarkers for Alzheimer's disease Classification and Progression#132281Unpaywall
• The Myokine Irisin Represents an Indirect Pathway Linking Exercise to Hippocampal Subfields Relevant to Alzheimer's Disease and Neurogenesis.#135729NCBI PubMed Central
• Detecting multimorbidity patterns in Alzheimer's disease using unsupervised machine learning: A nationwide emergency department study (2007-2022).#135768NCBI PubMed Central
• Detecting CSF-validated Alzheimer's disease from spontaneous speech in German: an interpretable end-to-end machine-learning framework.#138515NCBI PubMed Central
• Machine learning based on event-related oscillations of working memory differentiates between preclinical Alzheimer's disease and normal aging.#140877NCBI PubMed Central
• Ketogenic diet regulates Uch-L1(C) to improve cerebral energy metabolism and cognitive function in Alzheimer's disease mice.#143115NCBI PubMed Central
• Amyloid-beta statuses prediction with free water MR imaging features in Alzheimer's disease using machine learning models.#148241NCBI PubMed Central
• A mobile app (mWITH ME) for family caregivers of persons living with Alzheimer's disease: development and initial evaluation.#149999NCBI PubMed Central
• Single-Nuclei Transcriptomic Characterization of <i>APOE4</i> -Associated Alzheimer’s Disease#154132Unpaywall
• Cell-Type-Resolved Pseudobulk Classification Across Independent Cohorts Identifies Microglial PTPRG as a Transcriptional Hub in Alzheimer's Disease#165964bioRxiv / medRxiv
• What Alzheimer’s Is Doing While We’re Looking at Plaques : On The Receiver, The Signal, And The Disease That Is Neither#166973PhilArchive
• Circulating Sphingomyelins Correlate With Plasma T-Tau in Cognitively Unimpaired Older Adults at Risk of Developing Alzheimer's Disease.#170478NCBI PubMed Central
• Correlation between in vivo (18)F-flortaucipir PET and whole-brain postmortem histological tau signals in Alzheimer's disease.#174450NCBI PubMed Central
• A High-Throughput Assay for Monitoring and Quantifying Amyloid-β Accumulation and Clearance in Alzheimer's Disease Cell Models.#193312NCBI PubMed Central
• Community-Based Physician Attitudes Related to the Diagnosis and Treatment of Early Alzheimer's Disease in the United States.#195994NCBI PubMed Central
• Neurovascular-metabolic dysregulation, metabolic connectomics, and metabolic functional changes in Alzheimer's disease: A preclinical and clinical comparison.#209322NCBI PubMed Central
• Proteomics, Neuropsychological and Demographics Multimodal Machine Learning Approach to Alzheimer’s Disease Prediction on the Bio-Hermes Study Cohort#226694Goldsmiths Research Online
• Herbosomal nanocarriers using natural-origin surfactants: a quercetin-based strategy for Alzheimer's disease and oxidative-stress-driven neurodegeneration.#235945NCBI PubMed Central
• Long-term social isolation stress exacerbates sex-specific neurodegeneration markers in a natural model of Alzheimer’s disease#260606Repositorio USS
• Andrographolide modulates glucose metabolism in visceral adipose tissue in an Alzheimer&apos;s disease obese mouse model#263640Repositorio USS
• Integrating noise as a risk factor in studies of Alzheimer's disease and dementia: Guidance for epidemiologic research.#265595NCBI PubMed Central
• Clustering Properties of Neuronal Ryanodine Receptor 2 and Remodeling in the APP/PS1 Mouse Model of Alzheimer's Disease.#266805NCBI PubMed Central
• Unawareness of deficits in mild cognitive impairment: a systematic review of its role in progression to Alzheimer's disease.#297148NCBI PubMed Central
• Classifying Cognitive States of Alzheimer’s Disease with Machine Learning Using Digital Biomarkers from the Bio-Hermes Study Cohort#304391Goldsmiths Research Online
• Identifying single-nucleotide polymorphisms (SNPs) intersecting Alzheimer disease pathology and end-of-life traits using genomic informational field theory (GIFT)#307235bioRxiv / medRxiv
• Improving the clinical trial landscape for patients with atypical variants of Alzheimer's disease: a call to action.#308670NCBI PubMed Central
• Scalable CT-based prognostic modeling of dementia conversion in mild cognitive impairment#311558Europe PMC
• Tau positron emission tomography analysis methods for the quantification of tau spread in preclinical and early Alzheimer's disease.#312383NCBI PubMed Central
• Traumatic brain injury and late-life Alzheimer's disease neuropathology: Quantitative investigation in the Adult Changes in Thought study.#317976NCBI PubMed Central
• Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.#340275NCBI PubMed Central
• RDoC-informed explainable AI as a paradigm for multilevel Alzheimer's disease diagnosis and progression prediction: a systematic review.#340343NCBI PubMed Central
• Exercise and neural circuit stability in early Alzheimer's disease: evidence across memory, executive, cholinergic, and circadian systems.#351657NCBI PubMed Central